Bisolvine
NDC Package 14505-488-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Bisolvine is directions   Do not exceed 6 doses in 24 hours Age                                                                    DoseChildren 6 to under                               1 tablespoonful (15 mL)12 years of age                                    every 4 hoursChildren 2 to under                               1/2 tablespoonful (7.5 mL) 6 years of age                                      every 4 hoursChildren under 2 years of age                Consult your doctor. Marketed by Pharmalab Enterprises Inc., this product is identified by NDC 14505-488 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
14505-488-04
Package Description
120 mL in 1 BOTTLE, PLASTIC
Product Code
14505-488
11-Digit Billing Format
14505048804

Clinical Specifications

Proprietary Name
Bisolvine Child
Dosage Form
-
Usage Information
Directions   Do not exceed 6 doses in 24 hours Age                                                                    DoseChildren 6 to under                               1 tablespoonful (15 mL)12 years of age                                    every 4 hoursChildren 2 to under                               1/2 tablespoonful (7.5 mL) 6 years of age                                      every 4 hoursChildren under 2 years of age                Consult your doctor

Regulatory & Marketing

Labeler Name
Pharmalab Enterprises Inc.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
02-18-2010
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 14505-488-04 identifies a specific commercial package of 120 ml in 1 bottle, plastic of Bisolvine Child, labeled by Pharmalab Enterprises Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pharmalab Enterprises Inc. on February 18, 2010. The current certification is valid through December 31, 2018.

How is this Pharmalab Enterprises Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 14505048804. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
14505-488-04
11-Digit CMS (5-4-2)
14505-0488-04

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.